Gavin Leask, MD
Cardiovascular Disease · Florence, SCNPI 1548227804
Payments from drug & device makers
Across 365 payments — averaging $43.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$6K
- Medtronic$3K
- Novartis$712
- Pfizer$671
- Biotronik Inc.$476
- AstraZeneca$471
- plus $4K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 41 | $5,922 |
| Medtronic(2 entities) | 32 | $3,083 |
| Novartis | 48 | $712 |
| Pfizer | 31 | $671 |
| Biotronik Inc. | 20 | $476 |
| AstraZeneca | 20 | $471 |
| Merck | 21 | $467 |
| Johnson & Johnson | 19 | $345 |
| Amgen | 17 | $320 |
| Boston Scientific | 11 | $318 |
| Galderma Laboratories, L.p. | 7 | $318 |
| E.r. Squibb & Sons, L.L.C. | 20 | $301 |
| Vital Connect, Inc | 6 | $281 |
| Philips North America LLC | 7 | $265 |
| Abbott | 4 | $184 |
| AbbVie(2 entities) | 2 | $183 |
| Irhythm Technologies, Inc. | 11 | $182 |
| Edwards Lifesciences | 1 | $175 |
| Boehringer Ingelheim | 7 | $154 |
| Merz North America, Inc. | 1 | $140 |
| Novo Nordisk | 6 | $135 |
| Acist Medical Systems, Inc. | 4 | $117 |
| Sanofi-aventis U.S. LLC | 4 | $76 |
| Amarin Pharma, Inc. | 4 | $67 |
| Biosense Webster, Inc. | 1 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $61 |
| Cvrx, Inc. | 2 | $43 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Sanofi | 1 | $32 |
| Inari Medical, Inc. | 1 | $31 |
| Inspire Medical Systems, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Bayer | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 2 | $23 |
| Cardinal Health 200 LLC | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $14 |
How this compares
$15,818 in reported general payments places this provider in the 80th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Florence
- Brian BlakerFlorence$30K
- John PattonFlorence$29K
- Brent McLaurinAnderson$1.1M
- Robert BiedermanCharleston$801K
- James MerriamGreenville$728K
- Vipul ShahLancaster$488K
- Arthur EberlyGreenville$438K
- Gregory SanGreenville$429K
- Naresh MoriRock Hill$408K
- Priya KumarGreenwood$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.